Makoto Sugimori
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Somatic BRCA alterations in breast cancer are associated with distinct biological and clinical patterns according to germline BRCA status.
Journal: ESMO open
Published: March 22, 2026
Real-world evidence of chemotherapy effects in advanced pancreatic ductal adenocarcinoma: prognostic significance of TP53 status in gemcitabine plus nab-paclitaxel therapy.
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
A case of advanced esophagogastric junction cancer in which comprehensive genomic profiling by liquid biopsy led to the diagnosis of a second primary hepatocellular carcinoma.
Journal: International cancer conference journal
Published: December 23, 2025
TP53 mutation is associated with shorter treatment duration with CDK4/6 inhibitors, but not with immune checkpoint inhibitors, in ER-positive/HER2-negative breast cancer: real-world perspective.
Journal: Breast cancer research : BCR
Published: November 11, 2025
Development of a novel PIK3CA-mutated pancreatic tumor mouse model and evaluation of the therapeutic effects of a PI3K inhibitor.
Journal: PloS one
Published: November 07, 2024
A Case of Advanced Biliary Tract Cancer With EGFR Amplification That Responded to Necitumumab.
Journal: Cancer reports (Hoboken, N.J.)
Published: February 14, 2024
Clinical significance of circulating biomarkers of immune-checkpoint molecules with atezolizumab plus bevacizumab therapy in unresectable hepatocellular carcinoma.
Journal: Hepatology international
Published: January 02, 2024
Clinicopathological and Genetic Features in Superficial Nonampullary Duodenal Epithelial Tumors.
Journal: Gastroenterology research and practice
Published: November 21, 2023
BRCA2 reversion mutation confers resistance to olaparib in breast cancer.
Journal: Clinical case reports
Published: February 19, 2023
Last Updated: 09/26/2026